Date and analysis scripts: Inclusion of medicines to treat neuropathic pain on national essential medicines lists
收藏资源简介:
BACKGROUND<br>This repo contains the clean data file containing information on the listing of drugs (and their indication) recommended as first- or second-line treatments for the management of neuropathic pain on national essential medicines lists. The repo also includes the <i>R</i> analysis scripts, figure outputs, and the non-English drug and disease names used in the data extraction process. The work was done under the auspices of the Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain (IASP).<br><br>The 112 national essential medicine lists included in the analysis were obtained from the WHO. Copies of the documents can be downloaded at: https://www.dropbox.com/sh/b9ava7m6bkoxqsz/AAAOjZVK4Gqda9E7a6QCji6Ga?dl=0.<br>CITATION<br>Kamerman PR, Wadley AL, Davis KD, Hietaharju A, Jain P, Kopf A, Meyer A-C, Raja SN, Rice ASC, Smith BH, Treede R-D, Wiffen PJ. World Health Organization essential medicines lists: where are the drugs to treat neuropathic pain? <i>PAIN</i> <b>156</b>: 793–797, 2015. DOI: 10.1097/01.j.pain.0000460356.94374.a1<br>LICENSES<br><i>Data license</i><br><br>All data associated with the *WHO essential medicines lists: where are the drugs to treat neuropathic pain?* GitHub repository, and its secondary hostings on figshare.com, are made available under the Open Data Commons Attribution License (http://opendatacommons.org/licenses/by/v1.0).<br><i>Code license</i><br>The MIT License (MIT) <br>Copyright (c) 2015 Neuropathic Pain Special Interest Group (NeuPSIG) of the International Association for the Study of Pain (IASP)<br>Permission is hereby granted, free of charge, to any person obtaining a copy of this software and associated documentation files (the "Software"), to deal in the Software without restriction, including without limitation the rights to use, copy, modify, merge, publish, distribute, sublicense, and/or sell copies of the Software, and to permit persons to whom the Software is furnished to do so, subject to the following conditions:<br>The above copyright notice and this permission notice shall be included in all copies or substantial portions of the Software.<br>THE SOFTWARE IS PROVIDED "AS IS", WITHOUT WARRANTY OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE AND NONINFRINGEMENT. IN NO EVENT SHALL THE AUTHORS OR COPYRIGHT HOLDERS BE LIABLE FOR ANY CLAIM, DAMAGES OR OTHER LIABILITY, WHETHER IN AN ACTION OF CONTRACT, TORT OR OTHERWISE, ARISING FROM, OUT OF OR IN CONNECTION WITH THE SOFTWARE OR THE USE OR OTHER DEALINGS IN THE SOFTWARE.
背景 本代码仓库收录经整理的数据集文件,内含各国基本药物目录中被推荐作为神经性疼痛一线或二线治疗药物的相关信息(含其适应症)。本仓库同时附带R语言分析脚本、图表输出结果,以及数据提取过程中使用的非英语药物与疾病名称。本研究由国际疼痛研究协会(International Association for the Study of Pain, IASP)下属的神经性疼痛特别兴趣小组(Neuropathic Pain Special Interest Group, NeuPSIG)主导开展。 本分析纳入的112份国家基本药物目录均源自世界卫生组织(World Health Organization, WHO),相关文档副本可通过以下链接下载:https://www.dropbox.com/sh/b9ava7m6bkoxqsz/AAAOjZVK4Gqda9E7a6QCji6Ga?dl=0。 引用格式 Kamerman PR, Wadley AL, Davis KD, Hietaharju A, Jain P, Kopf A, Meyer A-C, Raja SN, Rice ASC, Smith BH, Treede R-D, Wiffen PJ. 世界卫生组织基本药物目录:治疗神经性疼痛的药物何在?《PAIN》,2015年,第156卷:793–797页。DOI: 10.1097/01.j.pain.0000460356.94374.a1 许可协议 数据许可协议 本GitHub仓库及figshare.com平台的二次托管内容中,与《WHO essential medicines lists: where are the drugs to treat neuropathic pain?》相关的全部数据,均遵循开放数据共享署名许可协议(Open Data Commons Attribution License, http://opendatacommons.org/licenses/by/v1.0)发布。 代码许可协议 MIT许可协议(MIT License) 版权所有 © 2015 国际疼痛研究协会(International Association for the Study of Pain, IASP)下属的神经性疼痛特别兴趣小组(Neuropathic Pain Special Interest Group, NeuPSIG) 特此免费授予任何获得本软件及相关文档文件(以下简称“软件”)副本的人以无限制使用本软件的权利,包括但不限于使用、复制、修改、合并、发布、分发、再许可和/或销售本软件副本的权利,并允许向其提供本软件的人员遵循下述条件: 上述版权声明与本许可声明应包含在本软件的所有副本或实质部分中。 本软件按“原样”提供,不附带任何明示或暗示的担保,包括但不限于适销性、特定用途适用性与非侵权性的担保。在任何情况下,作者或版权持有人均不对因本软件或本软件的使用或其他交易行为产生的任何索赔、损害赔偿或其他责任承担责任,无论是合同诉讼、侵权诉讼还是其他诉讼,无论是否因本软件、本软件的使用或其他交易行为引发或与之相关。



